The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Marek's Disease Vaccine Market Research Report 2024
Synopsis
Marek's Disease Vaccine is used to prevent Marek's disease in chickens, which is the three major diseases that endanger the healthy development of the chicken industry.
The global Marek's Disease Vaccine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Marek's Disease Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Marek's Disease Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Marek's Disease Vaccine include Merck, Ceva, Zoetis, Boehringer Ingelheim, Guangdong Wen's Dahuanong Biotechnology Co., Ltd., Merial, Ruipu Biopharmaceutical Co., Ltd., Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. and Beijing Huadu Shihua Biological Products Co., Ltd., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Marek's Disease Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Marek's Disease Vaccine.
Report Scope
The Marek's Disease Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Marek's Disease Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Marek's Disease Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck
Ceva
Zoetis
Boehringer Ingelheim
Guangdong Wen's Dahuanong Biotechnology Co., Ltd.
Merial
Ruipu Biopharmaceutical Co., Ltd.
Harbin Pharmaceutical Group Biological Vaccine Co., Ltd.
Beijing Huadu Shihua Biological Products Co., Ltd.
Guangxi Lichengdong Biological Co., Ltd.
Segment by Type
Bivalent Vaccine
Monovalent Vaccine
Segment by Application
Veterinary Pharmacy
Online Sale
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Marek's Disease Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Marek's Disease Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Marek's Disease Vaccine is used to prevent Marek's disease in chickens, which is the three major diseases that endanger the healthy development of the chicken industry.
The global Marek's Disease Vaccine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Marek's Disease Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Marek's Disease Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Marek's Disease Vaccine include Merck, Ceva, Zoetis, Boehringer Ingelheim, Guangdong Wen's Dahuanong Biotechnology Co., Ltd., Merial, Ruipu Biopharmaceutical Co., Ltd., Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. and Beijing Huadu Shihua Biological Products Co., Ltd., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Marek's Disease Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Marek's Disease Vaccine.
Report Scope
The Marek's Disease Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Marek's Disease Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Marek's Disease Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck
Ceva
Zoetis
Boehringer Ingelheim
Guangdong Wen's Dahuanong Biotechnology Co., Ltd.
Merial
Ruipu Biopharmaceutical Co., Ltd.
Harbin Pharmaceutical Group Biological Vaccine Co., Ltd.
Beijing Huadu Shihua Biological Products Co., Ltd.
Guangxi Lichengdong Biological Co., Ltd.
Segment by Type
Bivalent Vaccine
Monovalent Vaccine
Segment by Application
Veterinary Pharmacy
Online Sale
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Marek's Disease Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Marek's Disease Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Marek's Disease Vaccine Market Overview
1.1 Product Overview and Scope of Marek's Disease Vaccine
1.2 Marek's Disease Vaccine Segment by Type
1.2.1 Global Marek's Disease Vaccine Market Value Comparison by Type (2024-2030)
1.2.2 Bivalent Vaccine
1.2.3 Monovalent Vaccine
1.3 Marek's Disease Vaccine Segment by Application
1.3.1 Global Marek's Disease Vaccine Market Value by Application: (2024-2030)
1.3.2 Veterinary Pharmacy
1.3.3 Online Sale
1.3.4 Others
1.4 Global Marek's Disease Vaccine Market Size Estimates and Forecasts
1.4.1 Global Marek's Disease Vaccine Revenue 2019-2030
1.4.2 Global Marek's Disease Vaccine Sales 2019-2030
1.4.3 Global Marek's Disease Vaccine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Marek's Disease Vaccine Market Competition by Manufacturers
2.1 Global Marek's Disease Vaccine Sales Market Share by Manufacturers (2019-2024)
2.2 Global Marek's Disease Vaccine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Marek's Disease Vaccine Average Price by Manufacturers (2019-2024)
2.4 Global Marek's Disease Vaccine Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Marek's Disease Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Marek's Disease Vaccine, Product Type & Application
2.7 Marek's Disease Vaccine Market Competitive Situation and Trends
2.7.1 Marek's Disease Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Marek's Disease Vaccine Players Market Share by Revenue
2.7.3 Global Marek's Disease Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Marek's Disease Vaccine Retrospective Market Scenario by Region
3.1 Global Marek's Disease Vaccine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Marek's Disease Vaccine Global Marek's Disease Vaccine Sales by Region: 2019-2030
3.2.1 Global Marek's Disease Vaccine Sales by Region: 2019-2024
3.2.2 Global Marek's Disease Vaccine Sales by Region: 2025-2030
3.3 Global Marek's Disease Vaccine Global Marek's Disease Vaccine Revenue by Region: 2019-2030
3.3.1 Global Marek's Disease Vaccine Revenue by Region: 2019-2024
3.3.2 Global Marek's Disease Vaccine Revenue by Region: 2025-2030
3.4 North America Marek's Disease Vaccine Market Facts & Figures by Country
3.4.1 North America Marek's Disease Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Marek's Disease Vaccine Sales by Country (2019-2030)
3.4.3 North America Marek's Disease Vaccine Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Marek's Disease Vaccine Market Facts & Figures by Country
3.5.1 Europe Marek's Disease Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Marek's Disease Vaccine Sales by Country (2019-2030)
3.5.3 Europe Marek's Disease Vaccine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Marek's Disease Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific Marek's Disease Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Marek's Disease Vaccine Sales by Country (2019-2030)
3.6.3 Asia Pacific Marek's Disease Vaccine Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Marek's Disease Vaccine Market Facts & Figures by Country
3.7.1 Latin America Marek's Disease Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Marek's Disease Vaccine Sales by Country (2019-2030)
3.7.3 Latin America Marek's Disease Vaccine Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Marek's Disease Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Marek's Disease Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Marek's Disease Vaccine Sales by Country (2019-2030)
3.8.3 Middle East and Africa Marek's Disease Vaccine Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Marek's Disease Vaccine Sales by Type (2019-2030)
4.1.1 Global Marek's Disease Vaccine Sales by Type (2019-2024)
4.1.2 Global Marek's Disease Vaccine Sales by Type (2025-2030)
4.1.3 Global Marek's Disease Vaccine Sales Market Share by Type (2019-2030)
4.2 Global Marek's Disease Vaccine Revenue by Type (2019-2030)
4.2.1 Global Marek's Disease Vaccine Revenue by Type (2019-2024)
4.2.2 Global Marek's Disease Vaccine Revenue by Type (2025-2030)
4.2.3 Global Marek's Disease Vaccine Revenue Market Share by Type (2019-2030)
4.3 Global Marek's Disease Vaccine Price by Type (2019-2030)
5 Segment by Application
5.1 Global Marek's Disease Vaccine Sales by Application (2019-2030)
5.1.1 Global Marek's Disease Vaccine Sales by Application (2019-2024)
5.1.2 Global Marek's Disease Vaccine Sales by Application (2025-2030)
5.1.3 Global Marek's Disease Vaccine Sales Market Share by Application (2019-2030)
5.2 Global Marek's Disease Vaccine Revenue by Application (2019-2030)
5.2.1 Global Marek's Disease Vaccine Revenue by Application (2019-2024)
5.2.2 Global Marek's Disease Vaccine Revenue by Application (2025-2030)
5.2.3 Global Marek's Disease Vaccine Revenue Market Share by Application (2019-2030)
5.3 Global Marek's Disease Vaccine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Corporation Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Marek's Disease Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Merck Marek's Disease Vaccine Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Ceva
6.2.1 Ceva Corporation Information
6.2.2 Ceva Description and Business Overview
6.2.3 Ceva Marek's Disease Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Ceva Marek's Disease Vaccine Product Portfolio
6.2.5 Ceva Recent Developments/Updates
6.3 Zoetis
6.3.1 Zoetis Corporation Information
6.3.2 Zoetis Description and Business Overview
6.3.3 Zoetis Marek's Disease Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Zoetis Marek's Disease Vaccine Product Portfolio
6.3.5 Zoetis Recent Developments/Updates
6.4 Boehringer Ingelheim
6.4.1 Boehringer Ingelheim Corporation Information
6.4.2 Boehringer Ingelheim Description and Business Overview
6.4.3 Boehringer Ingelheim Marek's Disease Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Boehringer Ingelheim Marek's Disease Vaccine Product Portfolio
6.4.5 Boehringer Ingelheim Recent Developments/Updates
6.5 Guangdong Wen's Dahuanong Biotechnology Co., Ltd.
6.5.1 Guangdong Wen's Dahuanong Biotechnology Co., Ltd. Corporation Information
6.5.2 Guangdong Wen's Dahuanong Biotechnology Co., Ltd. Description and Business Overview
6.5.3 Guangdong Wen's Dahuanong Biotechnology Co., Ltd. Marek's Disease Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Guangdong Wen's Dahuanong Biotechnology Co., Ltd. Marek's Disease Vaccine Product Portfolio
6.5.5 Guangdong Wen's Dahuanong Biotechnology Co., Ltd. Recent Developments/Updates
6.6 Merial
6.6.1 Merial Corporation Information
6.6.2 Merial Description and Business Overview
6.6.3 Merial Marek's Disease Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Merial Marek's Disease Vaccine Product Portfolio
6.6.5 Merial Recent Developments/Updates
6.7 Ruipu Biopharmaceutical Co., Ltd.
6.6.1 Ruipu Biopharmaceutical Co., Ltd. Corporation Information
6.6.2 Ruipu Biopharmaceutical Co., Ltd. Description and Business Overview
6.6.3 Ruipu Biopharmaceutical Co., Ltd. Marek's Disease Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Ruipu Biopharmaceutical Co., Ltd. Marek's Disease Vaccine Product Portfolio
6.7.5 Ruipu Biopharmaceutical Co., Ltd. Recent Developments/Updates
6.8 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd.
6.8.1 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Corporation Information
6.8.2 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Description and Business Overview
6.8.3 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Marek's Disease Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Marek's Disease Vaccine Product Portfolio
6.8.5 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Recent Developments/Updates
6.9 Beijing Huadu Shihua Biological Products Co., Ltd.
6.9.1 Beijing Huadu Shihua Biological Products Co., Ltd. Corporation Information
6.9.2 Beijing Huadu Shihua Biological Products Co., Ltd. Description and Business Overview
6.9.3 Beijing Huadu Shihua Biological Products Co., Ltd. Marek's Disease Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Beijing Huadu Shihua Biological Products Co., Ltd. Marek's Disease Vaccine Product Portfolio
6.9.5 Beijing Huadu Shihua Biological Products Co., Ltd. Recent Developments/Updates
6.10 Guangxi Lichengdong Biological Co., Ltd.
6.10.1 Guangxi Lichengdong Biological Co., Ltd. Corporation Information
6.10.2 Guangxi Lichengdong Biological Co., Ltd. Description and Business Overview
6.10.3 Guangxi Lichengdong Biological Co., Ltd. Marek's Disease Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Guangxi Lichengdong Biological Co., Ltd. Marek's Disease Vaccine Product Portfolio
6.10.5 Guangxi Lichengdong Biological Co., Ltd. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Marek's Disease Vaccine Industry Chain Analysis
7.2 Marek's Disease Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Marek's Disease Vaccine Production Mode & Process
7.4 Marek's Disease Vaccine Sales and Marketing
7.4.1 Marek's Disease Vaccine Sales Channels
7.4.2 Marek's Disease Vaccine Distributors
7.5 Marek's Disease Vaccine Customers
8 Marek's Disease Vaccine Market Dynamics
8.1 Marek's Disease Vaccine Industry Trends
8.2 Marek's Disease Vaccine Market Drivers
8.3 Marek's Disease Vaccine Market Challenges
8.4 Marek's Disease Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Marek's Disease Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Marek's Disease Vaccine Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Marek's Disease Vaccine Market Competitive Situation by Manufacturers in 2023
Table 4. Global Marek's Disease Vaccine Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Marek's Disease Vaccine Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Marek's Disease Vaccine Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Marek's Disease Vaccine Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Marek's Disease Vaccine Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Marek's Disease Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Marek's Disease Vaccine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Marek's Disease Vaccine, Product Type & Application
Table 12. Global Key Manufacturers of Marek's Disease Vaccine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Marek's Disease Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Marek's Disease Vaccine as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Marek's Disease Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Marek's Disease Vaccine Sales by Region (2019-2024) & (K Units)
Table 18. Global Marek's Disease Vaccine Sales Market Share by Region (2019-2024)
Table 19. Global Marek's Disease Vaccine Sales by Region (2025-2030) & (K Units)
Table 20. Global Marek's Disease Vaccine Sales Market Share by Region (2025-2030)
Table 21. Global Marek's Disease Vaccine Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Marek's Disease Vaccine Revenue Market Share by Region (2019-2024)
Table 23. Global Marek's Disease Vaccine Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Marek's Disease Vaccine Revenue Market Share by Region (2025-2030)
Table 25. North America Marek's Disease Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Marek's Disease Vaccine Sales by Country (2019-2024) & (K Units)
Table 27. North America Marek's Disease Vaccine Sales by Country (2025-2030) & (K Units)
Table 28. North America Marek's Disease Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Marek's Disease Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Marek's Disease Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Marek's Disease Vaccine Sales by Country (2019-2024) & (K Units)
Table 32. Europe Marek's Disease Vaccine Sales by Country (2025-2030) & (K Units)
Table 33. Europe Marek's Disease Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Marek's Disease Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Marek's Disease Vaccine Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Marek's Disease Vaccine Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Marek's Disease Vaccine Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Marek's Disease Vaccine Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Marek's Disease Vaccine Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Marek's Disease Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Marek's Disease Vaccine Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Marek's Disease Vaccine Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Marek's Disease Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Marek's Disease Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Marek's Disease Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Marek's Disease Vaccine Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Marek's Disease Vaccine Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Marek's Disease Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Marek's Disease Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Marek's Disease Vaccine Sales (K Units) by Type (2019-2024)
Table 51. Global Marek's Disease Vaccine Sales (K Units) by Type (2025-2030)
Table 52. Global Marek's Disease Vaccine Sales Market Share by Type (2019-2024)
Table 53. Global Marek's Disease Vaccine Sales Market Share by Type (2025-2030)
Table 54. Global Marek's Disease Vaccine Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Marek's Disease Vaccine Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Marek's Disease Vaccine Revenue Market Share by Type (2019-2024)
Table 57. Global Marek's Disease Vaccine Revenue Market Share by Type (2025-2030)
Table 58. Global Marek's Disease Vaccine Price (US$/Unit) by Type (2019-2024)
Table 59. Global Marek's Disease Vaccine Price (US$/Unit) by Type (2025-2030)
Table 60. Global Marek's Disease Vaccine Sales (K Units) by Application (2019-2024)
Table 61. Global Marek's Disease Vaccine Sales (K Units) by Application (2025-2030)
Table 62. Global Marek's Disease Vaccine Sales Market Share by Application (2019-2024)
Table 63. Global Marek's Disease Vaccine Sales Market Share by Application (2025-2030)
Table 64. Global Marek's Disease Vaccine Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Marek's Disease Vaccine Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Marek's Disease Vaccine Revenue Market Share by Application (2019-2024)
Table 67. Global Marek's Disease Vaccine Revenue Market Share by Application (2025-2030)
Table 68. Global Marek's Disease Vaccine Price (US$/Unit) by Application (2019-2024)
Table 69. Global Marek's Disease Vaccine Price (US$/Unit) by Application (2025-2030)
Table 70. Merck Corporation Information
Table 71. Merck Description and Business Overview
Table 72. Merck Marek's Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Merck Marek's Disease Vaccine Product
Table 74. Merck Recent Developments/Updates
Table 75. Ceva Corporation Information
Table 76. Ceva Description and Business Overview
Table 77. Ceva Marek's Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Ceva Marek's Disease Vaccine Product
Table 79. Ceva Recent Developments/Updates
Table 80. Zoetis Corporation Information
Table 81. Zoetis Description and Business Overview
Table 82. Zoetis Marek's Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Zoetis Marek's Disease Vaccine Product
Table 84. Zoetis Recent Developments/Updates
Table 85. Boehringer Ingelheim Corporation Information
Table 86. Boehringer Ingelheim Description and Business Overview
Table 87. Boehringer Ingelheim Marek's Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Boehringer Ingelheim Marek's Disease Vaccine Product
Table 89. Boehringer Ingelheim Recent Developments/Updates
Table 90. Guangdong Wen's Dahuanong Biotechnology Co., Ltd. Corporation Information
Table 91. Guangdong Wen's Dahuanong Biotechnology Co., Ltd. Description and Business Overview
Table 92. Guangdong Wen's Dahuanong Biotechnology Co., Ltd. Marek's Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Guangdong Wen's Dahuanong Biotechnology Co., Ltd. Marek's Disease Vaccine Product
Table 94. Guangdong Wen's Dahuanong Biotechnology Co., Ltd. Recent Developments/Updates
Table 95. Merial Corporation Information
Table 96. Merial Description and Business Overview
Table 97. Merial Marek's Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Merial Marek's Disease Vaccine Product
Table 99. Merial Recent Developments/Updates
Table 100. Ruipu Biopharmaceutical Co., Ltd. Corporation Information
Table 101. Ruipu Biopharmaceutical Co., Ltd. Description and Business Overview
Table 102. Ruipu Biopharmaceutical Co., Ltd. Marek's Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Ruipu Biopharmaceutical Co., Ltd. Marek's Disease Vaccine Product
Table 104. Ruipu Biopharmaceutical Co., Ltd. Recent Developments/Updates
Table 105. Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Corporation Information
Table 106. Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Description and Business Overview
Table 107. Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Marek's Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Marek's Disease Vaccine Product
Table 109. Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Recent Developments/Updates
Table 110. Beijing Huadu Shihua Biological Products Co., Ltd. Corporation Information
Table 111. Beijing Huadu Shihua Biological Products Co., Ltd. Description and Business Overview
Table 112. Beijing Huadu Shihua Biological Products Co., Ltd. Marek's Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Beijing Huadu Shihua Biological Products Co., Ltd. Marek's Disease Vaccine Product
Table 114. Beijing Huadu Shihua Biological Products Co., Ltd. Recent Developments/Updates
Table 115. Guangxi Lichengdong Biological Co., Ltd. Corporation Information
Table 116. Guangxi Lichengdong Biological Co., Ltd. Description and Business Overview
Table 117. Guangxi Lichengdong Biological Co., Ltd. Marek's Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Guangxi Lichengdong Biological Co., Ltd. Marek's Disease Vaccine Product
Table 119. Guangxi Lichengdong Biological Co., Ltd. Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Marek's Disease Vaccine Distributors List
Table 123. Marek's Disease Vaccine Customers List
Table 124. Marek's Disease Vaccine Market Trends
Table 125. Marek's Disease Vaccine Market Drivers
Table 126. Marek's Disease Vaccine Market Challenges
Table 127. Marek's Disease Vaccine Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Marek's Disease Vaccine
Figure 2. Global Marek's Disease Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Marek's Disease Vaccine Market Share by Type in 2023 & 2030
Figure 4. Bivalent Vaccine Product Picture
Figure 5. Monovalent Vaccine Product Picture
Figure 6. Global Marek's Disease Vaccine Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Marek's Disease Vaccine Market Share by Application in 2023 & 2030
Figure 8. Veterinary Pharmacy
Figure 9. Online Sale
Figure 10. Others
Figure 11. Global Marek's Disease Vaccine Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Marek's Disease Vaccine Market Size (2019-2030) & (US$ Million)
Figure 13. Global Marek's Disease Vaccine Sales (2019-2030) & (K Units)
Figure 14. Global Marek's Disease Vaccine Average Price (US$/Unit) & (2019-2030)
Figure 15. Marek's Disease Vaccine Report Years Considered
Figure 16. Marek's Disease Vaccine Sales Share by Manufacturers in 2023
Figure 17. Global Marek's Disease Vaccine Revenue Share by Manufacturers in 2023
Figure 18. The Global 5 and 10 Largest Marek's Disease Vaccine Players: Market Share by Revenue in 2023
Figure 19. Marek's Disease Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 20. Global Marek's Disease Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Marek's Disease Vaccine Sales Market Share by Country (2019-2030)
Figure 22. North America Marek's Disease Vaccine Revenue Market Share by Country (2019-2030)
Figure 23. United States Marek's Disease Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Marek's Disease Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Marek's Disease Vaccine Sales Market Share by Country (2019-2030)
Figure 26. Europe Marek's Disease Vaccine Revenue Market Share by Country (2019-2030)
Figure 27. Germany Marek's Disease Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Marek's Disease Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Marek's Disease Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Marek's Disease Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Marek's Disease Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Marek's Disease Vaccine Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Marek's Disease Vaccine Revenue Market Share by Region (2019-2030)
Figure 34. China Marek's Disease Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Marek's Disease Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Marek's Disease Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Marek's Disease Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Marek's Disease Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. China Taiwan Marek's Disease Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Indonesia Marek's Disease Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Thailand Marek's Disease Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Malaysia Marek's Disease Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Latin America Marek's Disease Vaccine Sales Market Share by Country (2019-2030)
Figure 44. Latin America Marek's Disease Vaccine Revenue Market Share by Country (2019-2030)
Figure 45. Mexico Marek's Disease Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Brazil Marek's Disease Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Argentina Marek's Disease Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa Marek's Disease Vaccine Sales Market Share by Country (2019-2030)
Figure 49. Middle East & Africa Marek's Disease Vaccine Revenue Market Share by Country (2019-2030)
Figure 50. Turkey Marek's Disease Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Saudi Arabia Marek's Disease Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. UAE Marek's Disease Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Global Sales Market Share of Marek's Disease Vaccine by Type (2019-2030)
Figure 54. Global Revenue Market Share of Marek's Disease Vaccine by Type (2019-2030)
Figure 55. Global Marek's Disease Vaccine Price (US$/Unit) by Type (2019-2030)
Figure 56. Global Sales Market Share of Marek's Disease Vaccine by Application (2019-2030)
Figure 57. Global Revenue Market Share of Marek's Disease Vaccine by Application (2019-2030)
Figure 58. Global Marek's Disease Vaccine Price (US$/Unit) by Application (2019-2030)
Figure 59. Marek's Disease Vaccine Value Chain
Figure 60. Marek's Disease Vaccine Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
